Results 21 to 30 of about 5,568 (251)

Keberhasilan terapi fase inisial periodontal pada gingival enlargement pasien anak dengan hidrosefalus

The success of initial periodontal therapy phase in gingival enlargement paediatric patient with hydrocephalus

open access: yesJurnal Kedokteran Gigi Universitas Padjadjaran, 2020
Pendahuluan: gingival enlargement umumnya terjadi akibat inflamasi kronis yang disebabkan oleh faktor lokal, seperti induksi plak pada gingiva dan faktor sistemik seperti  pengaruh hormon dan obat-obatan sistemik tertentu.
Nunung Rusminah   +2 more
doaj   +1 more source

Idiopathic gingival fibromatosis with periodontitis: A rare case report and literature

open access: yesJournal of Medical Sciences, 2021
Idiopathic gingival fibromatosis (IGF) is a hereditary condition with esthetic, functional, and periodontal impairment in patients. It is slowly progressive in nature.
Shivani Sachdeva   +2 more
doaj   +1 more source

Phase Ib study of anlotinib combined with TQB2450 in pretreated advanced biliary tract cancer and biomarker analysis

open access: yesHepatology, EarlyView., 2022
Phase 1b study of anlotinib combined with TQB2450 in pretreated advanced biliary tract cancer and biomarker analysis. Abstract Background and Aims We evaluated the efficacy and safety of the antiangiogenic tyrosine kinase inhibitor anlotinib plus TQB2450, a programmed death‐ligand 1 inhibitor in pretreated advanced biliary tract cancers (BTCs ...
Jun Zhou   +13 more
wiley   +1 more source

Hereditary Gingival Fibromatosis: Report of Family Pedigree of Three Generations [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2019
Gingival enlargement or gingival overgrowth can be defined as increase in the size of gingiva, caused due to a variety of etiological factors. One of the causes of gingival enlargement is hereditary gingival fibromatosis, which is a genetic disorder ...
JAIDEEP MAHENDRA   +3 more
doaj   +1 more source

Phenytoin-induced gingival enlargement [PDF]

open access: yesBMJ Case Reports, 2014
Gingival overgrowth occurs as a side effect of some systemic medications. It is now well established that phenytoin is one such agent. It has multiple therapeutic indications ranging from convulsive disorders and neuralgias to cardiac arrhythmia. The incidence rate of phenytoin-induced gingival overgrowth ranges from 3% to 93%, but 50% of patients on ...
Lisa Neelathil, Chacko, Sathish, Abraham
openaire   +2 more sources

Gingival enlargement as oral manifestation in acute myeloid leukemia patient

open access: yesDental Journal, 2017
Background: Acute myeloid leukemia (AML) is a bone marrow cancer, a malignant disease that triggering the cells develops into different types of blood cells.
Sandra Olivia Kuswandani   +2 more
doaj   +1 more source

Nifedipine induced gingival enlargement in an edentulous patient: a case report with one year follow up

open access: yesBMC Oral Health, 2018
Background Gingival enlargement due to calcium channel blockers is a common complaint reported by patients. It can be localized or generalized and can range from mild to severe, affecting patients appearance and function.
Shaik Mohammed Asif   +6 more
doaj   +1 more source

Low dose amlodipine-induced gingival enlargement: A clinical case series

open access: yesContemporary Clinical Dentistry, 2015
Gingival enlargement sometimes has an adverse effect of certain systemic drugs such as the use of anticonvulsants, phenytoin, antihypertensive, calcium channel blockers and immunosuppressant, cyclosporine.
Amitandra Kumar Tripathi   +3 more
doaj   +1 more source

Amlodipine‐induced gingival enlargement

open access: yesClinical Case Reports, 2017
Key Clinical MessageThe three most common classes of medications implicated in drug‐induced gum enlargement are anticonvulsives, calcineurin inhibitors, and calcium channel blockers. Treatment primarily consists of withdrawing the offending agent whenever possible, in addition to maintaining good oral hygiene. Gingivectomy or flap surgery may be needed
Abhilash Koratala   +2 more
openaire   +2 more sources

A pH‐Switchable Cerium Single‐Atom Enzyme for Peri‐Implantitis Therapy via JAK‐STAT Signaling Axis‐Mediated Macrophage Reprogramming

open access: yesAdvanced Science, EarlyView.
A pH‐switchable cerium single‐atom enzyme is developed for stage‐specific peri‐implantitis therapy. Acidic conditions trigger antibacterial peroxidase‐like activity, whereas neutral conditions activate an antioxidant superoxide dismutase ‐ and catalase ‐like enzymatic relay. This microenvironment‐adaptive catalytic strategy suppresses the IL‐6/JAK‐STAT
Xiaomin Xia   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy